TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435

Clinical trial NCT01022125 · COMPLETED

Trial details

NCT number: NCT01022125
Sponsor: Tibotec Pharmaceuticals, Ireland
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis C Virus

Start date: 2010-01-01
Primary completion: 2010-04-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.